- Home
- CISO vs MIRA Comparison
CISO vs MIRA Comparison
Compare CISO & MIRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CISO
- MIRA
- Stock Information
- Founded
- CISO 2015
- MIRA 2020
- Country
- CISO United States
- MIRA United States
- Employees
- CISO N/A
- MIRA N/A
- Industry
- CISO Computer Software: Prepackaged Software
- MIRA Biotechnology: Pharmaceutical Preparations
- Sector
- CISO Technology
- MIRA Health Care
- Exchange
- CISO Nasdaq
- MIRA Nasdaq
- Market Cap
- CISO 31.4M
- MIRA 26.5M
- IPO Year
- CISO N/A
- MIRA 2023
- Fundamental
- Price
- CISO $1.29
- MIRA $1.29
- Analyst Decision
- CISO
- MIRA Strong Buy
- Analyst Count
- CISO 0
- MIRA 1
- Target Price
- CISO N/A
- MIRA $17.00
- AVG Volume (30 Days)
- CISO 685.4K
- MIRA 804.3K
- Earning Date
- CISO 11-17-2025
- MIRA 11-11-2025
- Dividend Yield
- CISO N/A
- MIRA N/A
- EPS Growth
- CISO N/A
- MIRA N/A
- EPS
- CISO N/A
- MIRA N/A
- Revenue
- CISO $28,792,765.00
- MIRA N/A
- Revenue This Year
- CISO N/A
- MIRA N/A
- Revenue Next Year
- CISO N/A
- MIRA N/A
- P/E Ratio
- CISO N/A
- MIRA N/A
- Revenue Growth
- CISO N/A
- MIRA N/A
- 52 Week Low
- CISO $0.30
- MIRA $0.73
- 52 Week High
- CISO $3.84
- MIRA $2.56
- Technical
- Relative Strength Index (RSI)
- CISO 68.68
- MIRA 40.50
- Support Level
- CISO $1.21
- MIRA $1.19
- Resistance Level
- CISO $1.47
- MIRA $1.72
- Average True Range (ATR)
- CISO 0.11
- MIRA 0.10
- MACD
- CISO 0.04
- MIRA -0.01
- Stochastic Oscillator
- CISO 70.30
- MIRA 18.25
About CISO CISO Global Inc.
CISO Global Inc provides cybersecurity services. The services are used to protect client's data, financial information, intellectual property, and business reputation. The services include penetration testing, security remediation, compliance auditing, vulnerability assessment, and others. Geographically, the company operates in U.S., Chile and All other countries. The maximum revenue is generated from U.S.
About MIRA MIRA Pharmaceuticals Inc.
Mira Pharmaceuticals Inc is a pre-clinical-stage pharmaceutical development company with two neuroscience programs targeting a broad range of neurologic and neuropsychiatric disorders. The company's novel oral pharmaceutical marijuana, MIRA-55, is under investigation for treating adult patients suffering from anxiety and cognitive decline, often associated with early-stage dementia.